PA

Parthipan Arumugasamy

Active Director Director DIN 07056401
DIN 07056401 First appointment Feb 2015 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2015
Shareholding value •••• Premium profile

About Parthipan Arumugasamy

Data last updated:

Parthipan Arumugasamy is a Director at Ps Arka Life Sciences Private Limited (since 2015). The company operates in Trading. Ps Arka Life Sciences Private Limited reported revenue of ₹4.9 Lakh (FY 2022).

DIN 07056401
Primary Designation Director
Industry Trading
First Appointment 12 Feb 2015
Oldest Company Age 11 yrs
Largest company Ps Arka Life Sciences Private Limited · ₹4.9 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Feb 20152015₹4.9 Lakh (FY 2022)Active

Board colleagues of Parthipan Arumugasamy

Directorship timeline

Open interactive timeline →
Ps Arka Life Sciences Private Limited
Premium access

Shareholding and investment profile for Parthipan Arumugasamy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Parthipan Arumugasamy

Parthipan Arumugasamy currently holds 1 directorship: Ps Arka Life Sciences Private Limited (Director, since 12 Feb 2015, revenue ₹4.9 Lakh (FY 2022)).

Parthipan Arumugasamy was first appointed on 12 Feb 2015 as Director at Ps Arka Life Sciences Private Limited.

The current boards of Parthipan Arumugasamy's companies include Manickam Chinna Durai Siva Sabari (Ps Arka Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available